Contact Us
Find A Doctor

INS115644 Ophthalmic Solution Clinical Trial

Principal Investigator 

Robert Ritch, M.D.

Objective

Evaluate the safety and efficacy of the new drug Latrunculin.

Eligibility

Over 40 years old, diagnosed with Primary Open Angle Glaucoma or Ocular Hypertension. No intraocular surgeries besides cataract surgery.

Enrollment Goal

15 participants (OPEN)

 

 

Contact Us

Glaucoma Associates of New York - Glaucoma Research InstituteTel: (212) 477-7540 ext 329

Address310 E. 14th Street
South Building, 5th Floor
New York, NY 10003

View all locations